Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 185,574 shares at $3.93 ($738K) on 2024-04-11, disclosed to the SEC on 2024-04-11.
Scheduled sale ($738k) by CHIEF STRATEGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 31,542 | $131K | 17.7% |
| 2 | $4.14 | 31,542 | $131K | 17.7% |
| 3 | $3.87 | 36,467 | $141K | 19.1% |
| 4 | $3.87 | 36,467 | $141K | 19.1% |
| 5 | $3.93 | 24,778 | $97K | 13.2% |
| 6 | $3.93 | 24,778 |
| $97K |
| 13.2% |
| Total | $3.98 avg | 185,574 | $738K | 100% |
| Filing → |
| AUGX | SELL | 2024-04-15 | $149K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $260K | — | Filing → |